HomeTagsAnnamycin

Annamycin

Biotechnology

Moleculin Provides Annamycin AML Program Update and Outlines

PR Newswire - February 15, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced preliminary results...

Biotechnology

Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

PR Newswire - December 28, 2021

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary interim...